This collection is approved, subject to the following change: The PLCO Cancer Screening Trial will alter the race/ethnicity categories used so that race/ethnicity data is collected in accordance with the 1997 OMB standards, cited in the Oct 30, 1997 copy of the Federal Register. This includes changes to the racial categories listed in Question 3 of the Eligibility Screenings and Question 2 of the Male and Female Baseline Questionnaires. In addition, the study should be altered so that it is in compliance with the OMB mandate that a participant be allowed to select more than one racial category. The new race/ ethnicity categories should be adopted for the remainder of the recuitment phase of this study.
Inventory as of this Action
Requested
Previously Approved
10/31/2002
10/31/2002
10/31/1999
1
0
192,737
94,809
0
114,537
0
0
0
This trial is designed to determine if screening for prostate, lung, colorectal, and ovarian cancer can reduce mortality from these cancers. Persons aged 55-74 will be randomized into two cohorts. One cohort will receive annual screening and the other usual care. Baseline and annual health status information will be obtained from all subjects.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.